We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+3.83%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$59.3B
AUM Growth
+$4.28B
Cap. Flow
+$3.01B
Cap. Flow %
5.08%
Top 10 Hldgs %
35.75%
Holding
917
New
47
Increased
651
Reduced
128
Closed
47

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$225M
2
TTE icon
TotalEnergies
TTE
+$216M
3
AAPL icon
Apple
AAPL
+$192M
4
MSFT icon
Microsoft
MSFT
+$170M
5
META icon
Meta Platforms (Facebook)
META
+$105M

Top Sells

Rank Stock Value
1
MRSH
Marsh
MRSH
+$96.3M
2
TAP icon
Molson Coors Class B
TAP
+$32.9M
3
K
Kellanova
K
+$29.9M
4
TJX icon
TJX Companies
TJX
+$23.6M
5
DD icon
DuPont de Nemours
DD
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 33.48%
2 Financials 14.04%
3 Communication Services 10.59%
4 Consumer Discretionary 10.41%
5 Healthcare 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEN icon
701
Penumbra
PEN
$12.5B
$518K ﹤0.01%
+1,665
New +$460K
HLNE icon
702
Hamilton Lane
HLNE
$3.63B
$517K ﹤0.01%
3,848
+623
+19% +$78.3K
FN icon
703
Fabrinet
FN
$17.1B
$516K ﹤0.01%
1,134
-212
-16% -$92.2K
IDR icon
704
Idaho Strategic Resources
IDR
$449M
$516K ﹤0.01%
12,811
-4,076
-24% -$156K
NMIH icon
705
NMI Holdings
NMIH
$3.25B
$516K ﹤0.01%
12,655
+560
+5% +$21.2K
RSI icon
706
Rush Street Interactive
RSI
$3.24B
$516K ﹤0.01%
26,559
+4,237
+19% +$78.3K
ACAD icon
707
Acadia Pharmaceuticals
ACAD
$4.25B
$516K ﹤0.01%
19,311
-942
-5% -$22.5K
NYT icon
708
New York Times
NYT
$11.6B
$514K ﹤0.01%
7,407
-826
-10% -$51.2K
MC icon
709
Moelis & Co
MC
$4.98B
$513K ﹤0.01%
7,470
+888
+13% +$59.3K
EPAM icon
710
EPAM Systems
EPAM
$4.69B
$513K ﹤0.01%
2,503
-484
-16% -$86.3K
WHD icon
711
Cactus
WHD
$3.83B
$512K ﹤0.01%
11,211
-436
-4% -$18.2K
RDVT icon
712
Red Violet
RDVT
$859M
$512K ﹤0.01%
8,985
-622
-6% -$33.7K
PAX icon
713
Patria Investments
PAX
$1.72B
$512K ﹤0.01%
32,198
-1,785
-5% -$26.7K
EXLS icon
714
EXL Service
EXLS
$4.23B
$511K ﹤0.01%
12,035
+1,006
+9% +$41.1K
DJCO icon
715
Daily Journal
DJCO
$792M
$510K ﹤0.01%
1,047
+34
+3% +$15.1K
AUPH icon
716
Aurinia Pharmaceuticals
AUPH
$1.97B
$508K ﹤0.01%
31,844
-6,832
-18% -$96.8K
CART icon
717
Maplebear
CART
$9.92B
$507K ﹤0.01%
11,279
+424
+4% +$17.4K
COCO icon
718
Vita Coco
COCO
$3.77B
$507K ﹤0.01%
9,569
-3,150
-25% -$148K
EVER icon
719
EverQuote
EVER
$886M
$507K ﹤0.01%
18,777
-1,603
-8% -$38.9K
CSW
720
CSW Industrials
CSW
$4.71B
$506K ﹤0.01%
1,725
-149
-8% -$39.7K
OSPN icon
721
OneSpan
OSPN
$562M
$506K ﹤0.01%
39,383
+8,094
+26% +$110K
KNSL icon
722
Kinsale Capital Group
KNSL
$7.95B
$505K ﹤0.01%
1,292
+194
+18% +$79.1K
LOPE icon
723
Grand Canyon Education
LOPE
$3.71B
$505K ﹤0.01%
3,038
+706
+30% +$128K
CXM icon
724
Sprinklr
CXM
$1.33B
$504K ﹤0.01%
64,789
+5,393
+9% +$41K
STOK icon
725
Stoke Therapeutics
STOK
$1.82B
$504K ﹤0.01%
15,871
-6,447
-29% -$194K

Similar funds

Aviva's Q4 2025 Portfolio in Review

As of Q4 2025, Aviva held 917 positions worth $59.3B, up 7.8% from $55B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Aviva deployed $3.01B of net new capital in Q4 2025, opening 47 new positions and adding to 651 existing holdings. Its largest new stake was TotalEnergies: 3,408,191 shares worth $222M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Marsh, an estimated $96.3M trimmed.

  • Aviva's largest Q4 2025 buy was TotalEnergies: 3,408,191 shares worth $222M.
  • Aviva added most to NVIDIA in Q4 2025, an estimated $225M increase.
  • Aviva's biggest Q4 2025 reduction was Marsh, cutting an estimated $96.3M.
  • Aviva fully exited Molson Coors Class B in Q4 2025, selling an estimated $32.9M.
  • Aviva's ten largest holdings make up 36% of its $59.3B portfolio in Q4 2025.
  • Aviva opened 47 new positions and closed 47 in Q4 2025.
  • Aviva's portfolio value rose 7.8% quarter-over-quarter to $59.3B.

Based on Aviva's 13F filing for Q4 2025, filed 12 Feb 2026.